Dong-E-E-Jiao Co., Ltd. (SZSE: 000423)
Health Care · Pharmaceuticals · CN
CN¥48.35
-6.30% today · -5.4% 1Y
Dong-E-E-Jiao Co., Ltd. (SZSE: 000423) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.59B and employs 4,345 people.
Over the last twelve months the share price has lost 5.4%, trading between 42.88 and 58.36.
Tweenvest scores Dong-E-E-Jiao Co., Ltd. across four factors: quality 75/100, value 63/100, growth 79/100, dividend 79/100. Its strongest factor is growth.
000423 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.59B
- Revenue (TTM)
- $1.00B
- P/E
- 17.42
- EPS
- 2.75
- Dividend yield
- 5.59%
- Beta (5Y)
- 0.03
- 52-week high
- CN¥58.36
- 52-week low
- CN¥42.88
- Avg volume (3M)
- —
- Shares outstanding
- 638.20M
- Employees
- 4,345
- Next earnings
- —
About Dong-E-E-Jiao Co., Ltd.
Established in 1952 and headquartered in Liaocheng, China, Dong-E-E-Jiao Co.,Ltd. is a prominent manufacturer and distributor of traditional Chinese remedies, biopharmaceuticals, and wellness food products throughout the Chinese market.
- ISIN
- CNE0000006Y9
- Founded
- 1952
- Listed since
- Jul 29, 1996
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,252.44 | -0.24% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.30 | +0.02% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $151.09 | -0.96% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.10 | -1.46% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £120.74 | -1.36% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.02 | -0.18% |
Figures last refreshed Aug 18, 2026.